VET PFAS Act
The VET PFAS Act protects veterans from PFAS exposure by enhancing medical care, funding research, and establishing a health registry to track their outcomes.
The VET PFAS Act protects veterans from PFAS exposure by enhancing medical care, funding research, and establishing a health registry to track their outcomes.
The VET PFAS Act (HR 3639) is a legislative proposal introduced in the House of Representatives on May 29, 2025. The bill aims to address the health and environmental concerns associated with per- and polyfluoroalkyl substances (PFAS) exposure among veterans.
The primary purpose of the VET PFAS Act is to:
- Protect veterans from the harmful effects of PFAS, which are often found in firefighting foam and various consumer products.
- Enhance research and support for veterans affected by PFAS exposure, ensuring they receive appropriate medical care and benefits.
While the specific text of the bill is not provided, the following key provisions are anticipated based on the bill's intent and context:
- Establishment of a PFAS Health Registry: The bill may propose the creation of a registry to track health outcomes of veterans exposed to PFAS.
- Increased Funding for Research: It is likely to allocate federal funds for research into the health impacts of PFAS on veterans, including studies on long-term effects and treatment options.
- Access to Medical Care: The bill may enhance access to medical care for veterans suffering from PFAS-related health issues, potentially including coverage for specific treatments and screenings.
- Education and Outreach Programs: The legislation could include provisions for educational programs to inform veterans about PFAS risks and available resources.
The VET PFAS Act primarily affects:
- Veterans: Those who have been exposed to PFAS through military service, particularly those involved in firefighting or stationed at military bases where PFAS were used.
- Veterans' Healthcare Providers: Medical professionals who will need to adapt to new guidelines and protocols for treating PFAS-related conditions.
- Research Institutions: Organizations that may receive funding to conduct studies on PFAS and its effects on health.
The VET PFAS Act is sponsored by:
- Michael Lawler (Primary Sponsor)
- Ro Khanna
- Madeleine Dean
- Seth Magaziner
- Josh Harder
- Brittany Pettersen
- Josh Riley
- Angie Craig
- Suzan K. DelBene
- Timothy M. Kennedy
- Maggie Goodlander
- Judy Chu
- Brian K. Fitzpatrick
- April McClain Delaney
- Steve Cohen
- Rashida Tlaib
- André Carson (Cosponsors)
The VET PFAS Act represents a significant step towards addressing the health risks associated with PFAS exposure among veterans. By establishing a framework for research, medical care, and education, the bill aims to improve the quality of life for those affected by these harmful substances. As the legislative process unfolds, further details and provisions will be clarified.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.